Search Results 151-160 of 17210 for hba1c

1. A Study Of Simvastatin Therapy For Moderate And Severe COPD - Mayo Clinic

   Elevated HbA1c > 6.5%. It is at the discretion of the Principal Investigator if the potential participant will not be a reliable study subject to complete ...

2. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

   HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. History of T1DM or any other type than type 2 (e.g. endocrinopathy, genetic ...

3. Ph 1b Study To Evaluate GSK2110183 In Combination With Bortezomib And Dexamethasone In Subjects With Multiple Myeloma - Mayo Clinic

   HbA1c≤8% at Screening visit; Adequate organ system function as defined in protocol. A female subject is eligible to participate if she is of non ...

4. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

   Poorly controlled Diabetes Mellitus (HbA1c>8). Clinical History Exclusion Criteria: Confirmed diagnosis of Diabetes Mellitus in use of insulin. Subjects ...

5. Statins and CPAP in Adipose Tissue of OSA - Mayo Clinic

   Fasting glucose > 120 mg/dL and/or HbA1c ≥ 6.5%. Females planning to be pregnant in next six months. Known serious or hypersensitivity to HMG-CoA reductase ...

6. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   HbA1c =< 7%. Women must not be pregnant or breast-feeding; all females of childbearing potential must have a blood test or urine study within 7 days of ...

7. Feasibility Of Autologous Adipose-derived Stromal Cells From Stromal Vascular Fraction (SVF) To Treat Adults With Pressure Ulcers Or Diabetic Foot Ulcers - Mayo Clinic

   Diabetes. HbA1c < 9. The ability of subjects to give appropriate consent or have an appropriate representative available to do so; The ability of subjects to ...

8. Diabetes care: 10 ways to avoid complications - Mayo Clinic

   This can lead to infections, ulcers that won't heal, and possible removal of one or more limbs, called amputation. Worse blood sugar management. Heart disease.

9. Evaluating Stem Cell Function in Patients with Chronic Kidney Disease (CKD) - Mayo Clinic

   HbA1c ≥ 11%. Subjects on therapeutic doses of anticoagulants [Warfarin (Coumadin), Rivaroxaban (Xarleto); Apixaban (Eliquis); Dabigatran (Pradaxa, Prazaxa)] ...

10. A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - Mayo Clinic

    The participant has a serum glycosylated hemoglobin (HbA1c) less than 9.5% at the Screening Visit. 5. The participant has a documented clinical diagnosis of ...